Activation domain-dependent mono-ubiquitylation of gal4 protein is essential for promoter binding in vivo

Autor: Fernando Gonzalez, Agnes Delahodde, Chase T. Archer, Stephen Albert Johnston, Thomas Kodadek
Přispěvatelé: SERRE, Marie-Claude, Institut de génétique et microbiologie [Orsay] (IGM), Université Paris-Sud - Paris 11 (UP11)-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2008
Předmět:
Proteasome Endopeptidase Complex
Saccharomyces cerevisiae Proteins
Molecular Sequence Data
Saccharomyces cerevisiae
Repressor
Models
Biological

Biochemistry
DNA-binding protein
03 medical and health sciences
0302 clinical medicine
[SDV.BBM] Life Sciences [q-bio]/Biochemistry
Molecular Biology

Transcription
Chromatin
and Epigenetics

[SDV.BBM]Life Sciences [q-bio]/Biochemistry
Molecular Biology

Amino Acid Sequence
Promoter Regions
Genetic

Molecular Biology
Transcription factor
Peptide sequence
[SDV.MP] Life Sciences [q-bio]/Microbiology and Parasitology
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
Adenosine Triphosphatases
chemistry.chemical_classification
0303 health sciences
DNA ligase
biology
Ubiquitin
Activator (genetics)
Ubiquitination
Promoter
Cell Biology
biology.organism_classification
Protein Structure
Tertiary

DNA-Binding Proteins
Repressor Proteins
[SDV.MP]Life Sciences [q-bio]/Microbiology and Parasitology
chemistry
Mutation
030217 neurology & neurosurgery
Transcription Factors
Zdroj: Journal of Biological Chemistry
Journal of Biological Chemistry, American Society for Biochemistry and Molecular Biology, 2008, 283 (18), pp.12614--23
ISSN: 0021-9258
1083-351X
Popis: The Saccharomyces cerevisiae Gal4 protein is a paradigmatic transcriptional activator containing a C-terminal acidic activation domain (AD) of 34 amino acids. A mutation that results in the truncation of about two-thirds of the Gal4AD (gal4D) results in a crippled protein with only 3% the activity of the wild-type activator. We show here that although the Gal4D protein is not intrinsically deficient in DNA binding, it is nonetheless unable to stably occupy GAL promoters in vivo. This is because of the activity of the proteasomal ATPases, including Sug1/Rpt6, which bind to Gal4D via the remainder of the AD and strip it off of DNA. A mutation that suppressed the Gal4D “no growth on galactose” phenotype repressed the stripping activity of the ATPase complex but not other activities. We further demonstrate that Gal4D is hypersensitive to this stripping activity because of its failure to be monoubiquitylated efficiently in vivo and in vitro. Evidence is presented that the piece of the AD that is deleted in Gal4D protein is likely a recognition element for the E3 ubiquitin-protein ligase that modifies Gal4. These data argue that acidic ADs comprise at least two small peptide subdomains, one of which is responsible for activator monoubiquitylation and another that interacts with the proteasomal ATPases, coactivators and other transcription factors. This study validates the physiological importance of Gal4 monoubiquitylation and clarifies its major role as that of protecting the activator from being destabilized by the proteasomal ATPases.
Databáze: OpenAIRE